Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PanFLOX: mFLOX in advanced pancreatic cancer
NCT02896803Phase 2Unknown
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Aug 2016
- Primary completion
- Jul 2021
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, folinic acid, oxaliplatin in pancreatic adenocarcinoma (PDAC), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.
02
Drugs
fluorouracilfolinic acidoxaliplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02896803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02896803.